SEC Form 4 · accession 0001104659-18-070335
NOVELION THERAPEUTICS INC. · NVLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Dennis Price
Officer — Chief Financial Officer
Period of report
Nov 27, 2018
Accepted (ET)
Nov 28, 2018 · 5:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827809
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 27, 2018 | F | 1,963 | $0.92 | D | 18,037 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares reported as disposed were withheld by the Issuer to satisfy tax withholding obligations of the Reporting Person related to the vesting of restricted stock units.